Estonia vs Finland: The number of people with susceptibility test result for rifampicin
Estonia
74
in 2021
Finland
87
in 2021
Estonia rank
113th
Finland rank
111th
The number of people with susceptibility test result for rifampicin over time
- Estonia
- Finland
How they compare
Finland currently reports 87 against 74 in Estonia, a difference of 13.
That makes Finland's figure about 1.2 times Estonia's.
Across all 5 years both countries report, Finland has been ahead every year.
Estonia ranks 113th and Finland ranks 111th of 155 countries.
Finland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Estonia | Finland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 111 | 127.33 | 16.33 | Finland |
| 2020s | 82.5 | 93.5 | 11 | Finland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Estonia or Finland?
- Finland, at 87 against 74 in Estonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Estonia and Finland?
- 13, with Finland ahead.
- How many years of comparable data are there for Estonia and Finland?
- 5 years are reported by both, from 2017 to 2021.
- How do Estonia and Finland rank globally for the number of people with susceptibility test result for rifampicin?
- Estonia ranks 113th and Finland ranks 111th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.